As FDA Eyes Cough/Cold Changes, Alternative Products Aim For Mainstream
This article was originally published in The Tan Sheet
Executive Summary
Some manufacturers are anticipating changes in FDA's findings on the safety and efficacy of OTC cough/cold medicines for 2- to 11-year-old children by promoting alternative products such as nasal decongestant sprays and washing devices
You may also be interested in...
Sea Changes In Regulation And The Market: Top Stories Of 2008
When an iconic drug brand drew scrutiny on Capitol Hill for possibly violating FDA's policy against combinations of drugs and dietary supplements, OTC and supplement interests took notice
Sea Changes In Regulation And The Market: Top Stories Of 2008
When an iconic drug brand drew scrutiny on Capitol Hill for possibly violating FDA's policy against combinations of drugs and dietary supplements, OTC and supplement interests took notice
Sea Changes In Regulation And The Market: Top Stories Of 2008
When an iconic drug brand drew scrutiny on Capitol Hill for possibly violating FDA's policy against combinations of drugs and dietary supplements, OTC and supplement interests took notice